Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.
Mitchell, Duane A
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide. [electronic resource] - Cancer immunology research Apr 2015 - 320-5 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2326-6074
10.1158/2326-6066.CIR-14-0100 doi
Antineoplastic Agents, Alkylating--adverse effects
Autoantibodies--biosynthesis
Cancer Vaccines--adverse effects
Combined Modality Therapy
Dacarbazine--adverse effects
Dendritic Cells--immunology
Glioblastoma--immunology
Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects
Humans
Male
Middle Aged
Temozolomide
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide. [electronic resource] - Cancer immunology research Apr 2015 - 320-5 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2326-6074
10.1158/2326-6066.CIR-14-0100 doi
Antineoplastic Agents, Alkylating--adverse effects
Autoantibodies--biosynthesis
Cancer Vaccines--adverse effects
Combined Modality Therapy
Dacarbazine--adverse effects
Dendritic Cells--immunology
Glioblastoma--immunology
Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects
Humans
Male
Middle Aged
Temozolomide